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Introduction
Chylothorax following oesophagectomy for cancer 
is reported to occur in 0–11% of patients (1,2). The 
development of a chyle leak (CL) has a detrimental impact 
on survival, disease recurrence, length of hospital stays and 
postoperative quality of life (3-9). There are 2 arguments for 
routine ligation and resection of the thoracic duct. Firstly, 
on an oncological basis, en bloc resection of the thoracic duct 
during oesophagectomy for oesophageal cancer has been 
reported to increase the number of resected mediastinal 
lymph nodes and ensures removal of potentially involved 
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nodes adjacent to the duct (10). Secondly, to prevent 
development of a chylothorax, the prophylactic mass 
ligation of the thoracic duct has been recommended with 
a randomized trial of 653 patients undergoing oesophageal 
resection reporting a chylothorax rate of 0.3% with ligation 
of the duct and 2.1% in patients with duct preservation (11). 
However, 2 recent systematic reviews and meta-analysis 
have reached different conclusions (12,13). Crucitti et al. 
reported a significant reduction in chylothorax rates with 
prophylactic ligation of the thoracic duct while Lei et al. 
found no evidence to support such an approach. Current 
practice in our unit is to routinely ligate the thoracic duct 
and remove all surrounding tissue en bloc. 
The aim of this study was to determine the rate of 
chylothorax within the unit and to identify patient, disease 
and surgical risk factors which predispose to CL following 
oesophagectomy. 
Methods
All patients who underwent subtotal oesophagectomy 
with formation of a gastric conduit and oesophago-
gastric anastomosis were included in a 3-year study period 
(January 2012–December 2014). Patients were identified 
from a prospectively collected database in a single tertiary 
referral centre. All operations were performed or supervised 
by 5 consultant specialist oesophago-gastric surgeons. 
Patients who underwent transhiatal and left thoraco-
abdominal procedures were excluded. Patients who 
developed anastomotic leak were excluded. Case notes 
were individually retrieved and reviewed retrospectively. 
All patients had placement of a feeding jejunostomy and 
feeding was commenced at 48 hours postoperatively at 
10 mL per hour then increased incrementally over the next 
few days using a standard protocol.
CL was diagnosed clinically in the majority of cases by 
the appearance of creamy hydrophobic fluid in the chest 
drain in the post-operative period on commencing enteral 
feeding. If confirmation was required drain fluid was tested 
for the presence of chylomicrons or for a triglyceride level 
greater than 100 mg/dL.
Statistical analysis was undertaken using SPSS version 
21 and STATA version 13.1. Fisher’s exact test was 
used to determine the association between outcome and 
categorical variables. Continuous variables were assessed 
for t-test assumptions, equal variance between groups, 
normal distribution, no significant outliers, by graphing and 
calculating descriptive statistics. If violations were identified 
data were log transformed to fit a normal distribution and/or 
an unequal variance design used. If non-normal distribution 
Mann-Whitney U test was used as a non-parametric test. P 
values of less than 0.05 was considered statistically significant.
Ethical approval was granted by the local Caldicott 
Guardian Council prior to data collection. All participants 
gave informed consent for anonymised data to be used for 
clinical research purposes at the time of surgery.
Results
During the 36-month study period 147 oesophagectomies 
were performed. Eighteen patients with anastomotic 
leak were excluded. Of the remaining 129 patients, 
11 developed a CL (8.5%). A total of 10 patients 
underwent thoracoscopic-assisted oesophagectomy with 
a cervical anastomosis and 119 an Ivor-Lewis 2-phase 
oesophagectomy with anastomosis in the upper thorax. The 
patient demographics are described in Table 1.
Patients with squamous cell carcinoma had a significantly 
increased risk of CL (6/16, 37.5%) when compared to 
patients with other tumour types (5/113, 4.4%, P=0.0005, 
Table 2). Patients with low BMI were more likely to develop 
a CL although this was not statistically significant (Table 1). 
Neither the extent of lymphadenectomy nor the extent of 
lymph node involvement (N stage) were associated with CL 
(Table 2).
Patients who developed a CL had both a prolonged ICU 
stay compared to those without a CL [8.3 days (5–16 days) 
Table 1 Patient demographics
Demographics
Control 
(N=118)
Chyle leak 
(N=11)
P value
Median age in yrs [IQR] 65 [58–72] 67 [61–77] 0.24
M:F 96:22 7:4 0.76
ASA [IQR] 2 [2–3] 2 [2–2]
BMI, mean (range) 27.5  
(24.0–30.3)
24.1  
(23.0–28.5)
0.098
CL (%)
CL in smokers 4/25 (16.0) 0.22
CL in non-smokers 7/104 (6.7)
CL with neoadj chemo 7/62 (11.3) 0.35
CL without neoadj chemo 4/67 (6.0)
Neoadj chemo, neoadjuvant chemotherapy; ASA, American 
Society of Anesthesiologists; CL, chyle leak.
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Table 2 Disease demographics
Demographics Control (N=118) (%) Chyle leak (N=11) (%) P value
Tumour location
–
Middle third 10/118 (8.5) 1/11 (9.1)
Lower third 81/118 (68.6) 10/11(90.9)
OGJ 1 13/118 (11.0) 0/11 (0)
OGJ 2 14/118 (11.9) 0/11 (0)
Pathology
Adenocarcinoma 96/118 (81.4) 5/11 (45.5)
Squamous 10/118 (8.5) 6/11 (54.5) 0.0005
Other 12/118 (10.2) 0/11 (0)
Staging
–
Tx 1/118 (0.8) 0/11 (0)
T1 36/118 (30.5) 0/11 (0)
T2 14/118 (11.9) 1/11 (9.1)
T3 61/118 (51.7) 9/11 (81.8)
T4 5/118 (4.2) 1/11 (9.1)
Melanoma 1/118 (0.8) 0/11 (0)
Nodal stage
–
N0 51/118 (43.2) 4/18 (22.2)
N1 31/118 (26.3) 5/18 (27.8)
N2 23/118 (19.5) 5/18 (27.8)
N3 12/118 (10.2) 4/18 (22.2)
Melanoma 1/118 (0.8) 0/18 (0)
Neurovascular invasion (yes) 74/118 (62.7) 9/11 (81.8) –
Mean No. of LNs examined, [range] 20.9 [5–50] 25 [9–40] 0.17
Mean No. of LNs positive, [range] 2.3 [0–18] 4.9 [0–23] 0.18
OGJ, oesophagogastric junction.
vs. 5.8 days (2–19 days), P=0.01] and a prolonged total 
inpatient stay [24.5 days (14–62 days) vs. 18.2 days (9– 
84 days), P=0.01] (Table 3). 
On day 1 post-operatively both groups of patients had 
similar median chest drain volumes, median volume 715.5 mL 
(200–1,550 mL) in patients who subsequently developed 
a CL and 532.1 mL (25–1,025 mL) in patients who did 
not (P=0.08) (Table 4). In comparison on day 2, prior to 
commencing enteral feeding, patients who subsequently 
developed a CL had a significantly higher chest drain 
volume compared to those who did not, 970.5 mL (100–
2,000 mL) vs. 541.2 mL (125–4,225 mL), P=0.003. Using a 
chest drain volume threshold of 600 mL on day 2, prior to 
commencing enteral feeding or the appearance of chyle, the 
sensitivity and specificity for predicting a CL was 92% and 
82% respectively.
Six of the 11 (54.5%) patients with a CL had a reduction 
in chest drainage to <600 mL/24 h after introduction 
of conservative measures (Table 5). All were successfully 
managed with non-operative treatment. Five patients 
with high volume CL (>600 mL/24 h despite conservative 
management) underwent re-thoracotomy. At the time of 
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re-operation, the main thoracic duct was never the source 
of leakage with numerous lymphatic channels throughout 
the mediastinal region of dissection the source. These were 
controlled with insertion of sutures at multiple levels. This 
achieved control in 4 cases with 1 patient subsequently 
requiring the insertion of a pleura-peritoneal shunt. 
Discussion
The routine practice of ligation of the thoracic duct has not 
prevented the development of chylothorax post-operatively 
in our unit. While the leak rate is 8.5% overall, the risk 
of developing a leak is greatly increased in patients with 
squamous cell carcinoma. The reason for this is unclear but 
may relate to lymphatic changes occurring in squamous 
cell carcinoma that increase the likelihood of a CL. The 
knowledge that at the time of re-operation the source of 
the leak was never the main thoracic duct encourages a 
conservative approach to CL in low volume cases, taken as 
<600 mL/24 h in our unit. This includes initially changing 
from a standard enteral feed to a medium-chain triglyceride 
(MCT) feed and then to total parenteral nutrition (TPN) 
if chest drain volumes do not decrease quickly. Based 
on these criteria all patients selected for conservative 
management were successfully treated. A chest drainage of 
>600 mL/24 h despite appropriate conservative measures 
is best treated with a re-thoracotomy at an early stage. The 
mediastinal lymphatic channels causing the CL are often 
sizeable and can be successfully controlled with additional 
sutures in the majority of cases. Fifty mL of cream is 
administered via the jejunostomy just prior to surgery to aid 
the identification of the lymphatic channels.
In post oesophagectomy patients the daily chest drainage 
volume is reported to be highest on the first post-operative 
day and then reduces daily over time (14). This is similar 
in our study with patients who did not develop either a 
chyle or anastomotic leak (N=118) (Figure 1). In contrast, 
patients who developed a CL had higher chest drain 
volumes on day 1 and the volumes remained high on the 
Table 3 Procedural demographics
Demographics Control (N=118) (%) Chyle leak (N=11) (%) P value
Mean total intraoperative blood loss [range], mL 560.2 [50–3,900] 399.1 [200–700] 0.30
Mean total operating time [range], min 391.2 [380–540] 367.7 [300–500] 0.91
Stapled anastomosis (yes) 74/118 (62.7) 8/11 (72.7) 0.76
Lap gastric mobilisation (yes) 14/118 (11.9) 2/11 (18.2) –
Lap oesophageal mobilisation (yes) 10/118 (8.5) 0/11 (0) –
Abdo phase performed by trainee (yes) 64/118 (54.2) 4/11 (36.4) –
Chest phase performed by trainee (yes) 53/118 (44.9) 6/11 (54.5) –
Mean ICU stay ventilated [range], days 1.8 [0–55] 0 [0–0] 0.23
Mean ICU stay unventilated [range], days 5.8 [2–19] 8.3 [5–16] 0.01
Mean duration of admission [range], days 18.2 [9–84] 24.5 [14–62] 0.01
New AF (yes) 15/118 (12.7) – –
AF, atrial fibrillation. 
Table 4 Daily total chest drain volumes (in mL, median)
Day Control (N=118) Chyle leak (N=11) P value
Day 0 532.1 [25–1,025] 715.5 [200–1,550] 0.08
Day 1 541.2 [125–4,225] 970.5 [100–2,000] 0.003
Day 2 364.0 [25–1,225] 907.3 [300–1,800] <0.0001
Day 3 286.7 [25–825] 944.6 [150–2,275] 0.0001
Day 4 195.9 [0–700] 724.1 [235–1,575] <0.0001
Day 5 126.1 [0–565] 627.3 [175–1,500] <0.0001
Day 6 93.1 [0–400] 509.1 [25–1,625] <0.0001
Day 7 69.1 [0–350] 425.0 [0–1,900] 0.0003
Day 8 53.7 [0–350] 400.0 [30–1,020] 0.0001
Day 9 38.2 [0–225] 320.0 [0–725] <0.0001
Day 10 37.3 [0–200] 430.6 [0–925] <0.0001
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second post-operative day prior to starting enteral feeding 
or the appearance of chyle. This should raise a high level of 
suspicion particularly in those with squamous cell cancer of 
a possible impending problem.
Previous studies have shown that patients with low 
BMI, squamous cell carcinoma and advanced nodal disease 
(high number of positive lymph nodes) predispose to a CL 
(15-17). The results of this study would suggest that neither 
the radicality of lymph node dissection nor extent of lymph 
node involvement increased the risk of CL. 
In conclusion, this study demonstrates squamous cell 
carcinoma remains a significant risk factor for the development 
of post-oesophagectomy chylothorax despite the routine 
ligation of the thoracic duct. In the knowledge that with 
this approach the main thoracic duct is never the source of 
CL, patients with a chest drainage of <600 mL/24 h can be 
successfully treated conservatively. Patients with a chest drain 
volume of >600 mL/24 h despite conservative management 
should under re-thoracotomy at an early stage.
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